Residency · Residency · Physical Medicine Rehabilitation

Disorders of Consciousness: Assessment and Prognosis

Classification

Coma

State of unarousable unresponsiveness with eyes closed. No sleep-wake cycle on EEG. No purposeful movements; no awareness. GCS typically 3-8.

Usually a transient state lasting days to weeks; patients either recover, progress to brain death, or transition to vegetative state.

Vegetative State (VS) / Unresponsive Wakefulness Syndrome (UWS)

Eyes open spontaneously or in response to stimulation (sleep-wake cycles present). No evidence of awareness of self or environment. No reproducible, purposeful, or voluntary behavioral response to stimuli. Reflexive and patterned responses may be present (posturing, grimacing, startle).

Terminology shift: "unresponsive wakefulness syndrome" preferred by some to reduce negative connotations. Persistent VS: present for >1 month. Permanent VS: after 3 months (non-traumatic) or 12 months (traumatic) -- recovery considered exceedingly unlikely but not impossible.

Minimally Conscious State (MCS)

Evidence of limited but clearly discernible self- or environmental awareness. Inconsistent but reproducible behavioral evidence of consciousness. Divided into MCS+ and MCS- based on presence of language-related behaviors.

MCS-Minus (MCS-)

Visual fixation and pursuit (sustained visual tracking). Localization of noxious stimuli. Contingent behavioral responses (e.g., crying or smiling in response to emotional stimuli). Reaching toward objects.

MCS-Plus (MCS+)

Command following (even if inconsistent). Intelligible verbalization. Intentional communication (yes/no responses). Functional object use.

Emergence from MCS

Defined by reliable and consistent functional communication OR functional use of objects. Marks transition to post-traumatic confusional state in TBI.

Confusional State

Agitated or hypoactive; disoriented; impaired attention. Clear evidence of awareness but confused. Post-traumatic amnesia (PTA) period in TBI. Assessed with Galveston Orientation and Amnesia Test (GOAT) or Orientation Log (O-Log).

<image>Hierarchical diagram showing the spectrum of disorders of consciousness from coma through vegetative state/unresponsive wakefulness syndrome, minimally conscious state minus and plus, emergence from MCS, to confusional state, with defining behavioral criteria listed at each level and typical temporal progression</image>

Assessment Tools

Coma Recovery Scale-Revised (CRS-R)

Gold standard bedside behavioral assessment for disorders of consciousness. Six subscales: auditory, visual, motor, oromotor, communication, arousal. Hierarchical items within each subscale from reflexive to intentional. Total score range: 0-23.

Diagnostic criteria for VS, MCS-, MCS+, and emergence from MCS are embedded. Should be administered by trained clinicians; takes 20-30 minutes. Recommended to administer multiple times (minimum 5 assessments) because patients may fluctuate. Misdiagnosis rate between VS and MCS may exceed 40% without standardized assessment.

Glasgow Coma Scale (GCS)

Most widely used scale in acute care settings. Components: eye opening (1-4), verbal response (1-5), motor response (1-6). Total score range: 3-15. Limitations: does not distinguish VS from MCS; confounded by intubation, sedation, and facial injuries. Not designed for prolonged disorders of consciousness.

Other Assessment Tools

JFK Coma Recovery Scale: precursor to the CRS-R. FOUR Score (Full Outline of UnResponsiveness): overcomes some GCS limitations; includes brainstem reflexes and breathing pattern; range 0-16. Disability Rating Scale (DRS): tracks recovery across the full spectrum from coma to community reintegration. Rancho Los Amigos Scale (RLAS): descriptive levels I-X of cognitive functioning and recovery after TBI.

Neuroimaging for Prognosis

Structural MRI

Diffuse axonal injury patterns (corpus callosum, brainstem, gray-white junction) on susceptibility-weighted imaging (SWI). Extent of injury correlates with prognosis. Brainstem lesions carry particularly poor prognostic implications. Thalamic and widespread cortical injury suggest poor recovery potential.

Functional MRI (fMRI)

Task-based fMRI can detect covert awareness in patients behaviorally diagnosed as VS. Owen et al. (2006): patient in VS demonstrated mental imagery of playing tennis (supplementary motor area activation) and navigating a house (parahippocampal gyrus activation). Estimated 15-20% of VS patients may have covert cognitive abilities detectable on fMRI. Research tool; not widely available for clinical use.

PET Imaging

FDG-PET can assess cortical metabolic activity. Metabolic threshold correlates with level of consciousness. Higher metabolic activity in associative cortex predicts better recovery.

Electrophysiology

EEG: presence of reactive, organized background activity is favorable; isoelectric or burst-suppression patterns are poor prognostic signs. Event-related potentials (ERPs): presence of P300 (cognitive processing of novelty) and mismatch negativity (MMN) suggests some preserved cortical processing. Somatosensory evoked potentials (SSEPs): bilateral absence of N20 cortical response after cardiac arrest carries very poor prognosis (near 100% specificity for poor outcome).

<image>Illustration comparing fMRI activation patterns in a healthy control, a minimally conscious state patient, and a vegetative state patient with covert awareness, showing task-related activation in motor imagery and spatial navigation paradigms, demonstrating that some VS patients have preserved cognitive processing undetectable by bedside examination</image>

Prognostic Considerations

Traumatic vs. Non-Traumatic Etiology

Traumatic etiologies have significantly better recovery potential than non-traumatic (anoxic, vascular). Traumatic VS: recovery of consciousness possible up to 12 months (and occasionally beyond). Non-traumatic VS: recovery of consciousness after 3 months is exceedingly rare. Age, initial GCS, pupillary reactivity, and imaging findings all influence prognosis.

Prognostic Indicators for Recovery

Favorable: younger age, traumatic etiology, higher CRS-R scores early, visual pursuit/fixation, command-following, preserved cortical SSEPs, reactive EEG. Unfavorable: older age, anoxic etiology, absent SSEPs (N20), burst-suppression or isoelectric EEG, extensive brainstem and thalamic injury, bilateral absent pupillary reflexes, prolonged duration in VS. No single test is sufficient for prognostication; multimodal assessment is essential.

Late Recovery

Case reports of late recovery from VS/MCS beyond traditional windows. Recovery to functional independence is rare after prolonged VS (>6 months traumatic, >3 months non-traumatic). MCS patients have better long-term outcomes than VS patients. The distinction between VS and MCS has critical prognostic implications.

Medical Management

Common Medical Issues

Paroxysmal sympathetic hyperactivity: tachycardia, hypertension, diaphoresis, posturing, fever; managed with beta-blockers, bromocriptine, gabapentin. Seizures: continuous EEG monitoring in acute phase; antiepileptic prophylaxis. Hydrocephalus: monitor head circumference and serial imaging; may require VP shunt. Neuroendocrine dysfunction: panhypopituitarism, SIADH, diabetes insipidus, hypothyroidism.

Spasticity and contracture prevention: stretching, positioning, splinting, pharmacologic management. Nutritional support: typically PEG tube for prolonged DOC; caloric needs assessment. Skin integrity: pressure injury prevention with frequent repositioning. DVT prophylaxis: pharmacologic and mechanical prophylaxis.

Pharmacologic Neuromodulation

Amantadine: the only medication with Level 1 evidence (Giacino et al., NEJM 2012) for accelerating recovery in DOC after TBI; 100-200 mg BID; initiated 4-16 weeks post-injury. Zolpidem: paradoxical awakening effect in some patients; response rate approximately 5-7%; trial-worthy even if low response rate. Methylphenidate: may improve arousal and processing speed; limited evidence. Modafinil: wakefulness-promoting agent; anecdotal benefit. Avoid medications that may impair recovery: benzodiazepines, typical antipsychotics, phenytoin.

Ethical and Family Considerations

Communication with Families

Families need clear, honest, and compassionate communication about diagnosis and prognosis. Explain the difference between VS and MCS and its prognostic significance. Acknowledge uncertainty; avoid premature definitive prognostication. Serial reassessment and communication are essential. The high misdiagnosis rate should be disclosed; standardized assessment (CRS-R) reduces error.

Decision-Making

Advanced directives and prior expressed wishes guide care when available. Surrogate decision-making based on substituted judgment or best interest standards. Decisions about life-sustaining treatment (nutrition, hydration, ventilation) are individualized. Ethics committee involvement may be helpful in complex cases.

Rehabilitation Considerations

Patients in MCS have rehabilitation potential and should have access to rehabilitation services. Structured sensory stimulation programs may be beneficial in the early phases. Transfer to specialized neurorehabilitation centers improves outcomes. Long-term planning: skilled nursing facility, specialized DOC programs, or home care with support.

Clinical Pearls

The CRS-R should be administered multiple times (at least 5); patients fluctuate and single assessments frequently underestimate awareness. Visual pursuit (sustained tracking) is one of the earliest and most important signs distinguishing MCS from VS. Misdiagnosis of VS when the patient is actually in MCS occurs in up to 40% of cases without standardized assessment; this has profound ethical and treatment implications. Amantadine is the only medication with strong evidence for DOC after TBI; consider it for all eligible patients.

Zolpidem is worth trialing given its low cost and occasional dramatic response, even though most patients will not respond. FMRI studies have shown covert awareness in some patients diagnosed as VS, challenging our ability to determine consciousness from behavior alone. The distinction between "persistent" and "permanent" VS matters for prognostic counseling; traumatic etiology allows a longer window of potential recovery. Always assess and treat potentially reversible factors that may suppress consciousness: hydrocephalus, seizures, metabolic derangements, sedating medications, infection.

References

• Giacino JT, et al. Placebo-Controlled Trial of Amantadine for Severe Traumatic Brain Injury. N Engl J Med. 2012;366(9):819-826.
• Giacino JT, et al. The JFK Coma Recovery Scale-Revised: Measurement Characteristics and Diagnostic Utility. Arch Phys Med Rehabil. 2004;85(12):2020-2029.
• Owen AM, et al. Detecting Awareness in the Vegetative State. Science. 2006;313(5792):1402.
• Multi-Society Task Force on PVS. Medical Aspects of the Persistent Vegetative State. N Engl J Med. 1994;330(21):1499-1508.
• Kondziella D, et al. European Academy of Neurology Guideline on the Diagnosis of Coma and Other Disorders of Consciousness. Eur J Neurol. 2020;27(5):741-756.

Read this lecture as Markdown